Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
NPJ Genomic Medicine|September 25, 2024
CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcomaKarim H Saba, Valeria Difilippo, Emelie Styring, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 31, 2021
Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumorFlorian Puls, Jodi M Carter, Nischalan Pillay, et al.
The American Journal of Pathology|July 17, 2012
Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumorsSamuel Gebre-Medhin, Karolin H Nord, Emely Möller, et al.
The American Journal of Surgical Pathology|December 21, 2018
PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 CasesFlorian Puls, Nischalan Pillay, Henrik Fagman, et al.
The Journal of Pathology|November 27, 2023
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathwayKarim H Saba, Valeria Difilippo, Michal Kovac, et al.
The Journal of Pathology. Clinical Research|June 17, 2020
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastomaKarim H Saba, Louise Cornmark, Jakob Hofvander, et al.
Scandinavian Journal of Work, Environment & Health|June 1, 2022
Workplace bullying and risk of suicide and suicide attempts: A register-based prospective cohort study of 98 330 participants in DenmarkPaul Maurice Conway, Annette Erlangsen, Matias Brødsgaard Grynderup, et al.
Pageof 8